| 2026 |
Subphenotype-
and complication-guided adjunctive fosfomycin versus standard
monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two
randomised trials
|
19016 |
SAFO |
RESULTADOS |
Enfermedades Infecciosas |
| 2026 |
Subphenotype-
and complication-guided adjunctive fosfomycin versus standard
monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two
randomised trials
|
14007 |
BACSARM |
RESULTADOS |
Enfermedades Infecciosas |
| 2025 |
Effectiveness of oral step-down therapy and early oral
switch for bloodstream infections caused by Enterobacterales: A post hoc
emulation trial of the SIMPLIFY trial
|
16.001 |
SIMPLIFY |
RESULTADOS |
Enfermedades Infecciosas |
| 2023 |
Evaluation of the
effectiveness and safety of oral vancomycin versus placebo in the
prevention of recurrence of Clostridioides difficile infection in
patients under systemic antibiotic therapy: a phase III, randomised,
double-blind clinical trial.
|
19.010 |
PREVAN |
PROTOCOLO |
Enfermedades Infecciosas |
| 2023 |
Antibiotic use and outcome
in patients with negative blood cultures, a new target population for
antimicrobial stewardship interventions: a prospective multicentre
cohort (NO-BACT)
|
18.010 |
NO_BACT |
RESULTADOS |
Enfermedades Infecciosas |
| 2026 |
Randomized
double-blind clinical trial evaluating the effectiveness and safety of
secondary prophylaxis with oral vancomycin versus placebo in the
prevention of recurrence of clostridioides difficile infection in
patients receiving systemic antibiotic therapy (PREVAN trial)
|
19.010 |
PREVAN |
RESULTADOS |
Enfermedades Infecciosas |
| 2024 |
Eficacia de la
infusión extendida de los antibióticos B-lactámicos en el tratamiento de
la neutropenia febril en los pacientes hematológicos
|
19.017 |
BEATLE |
RESULTADOS |
Enfermedades Infecciosas |
| 2024 |
Efficacy and
safety of a structured de-escalation from antipseudomonal β-lactams in
bloodstream infections due to Enterobacterales (SIMPLIFY): an
open-label, multicentre, randomised trial
|
16.001 |
SIMPLIFY |
RESULTADOS |
Enfermedades Infecciosas |
| 2023 |
Efficacy and
safety of different antimicrobial DURATions for the treatment of
Infections associated with Osteosynthesis Material implanted after long
bone fractures (DURATIOM): Protocol for a randomized, pragmatic
trial
|
21.012 |
DURATIOM |
PROTOCOLO |
Enfermedades Infecciosas |
| 2023 |
Randomised,
open-label, non-inferiority clinical trial on the efficacy and safety of
a 7-day vs 14-day course of antibiotic treatment for uncomplicated
enterococcal bacteraemia: the INTENSE trial protocol
|
21.032 |
INTENSE |
PROTOCOLO |
Enfermedades Infecciosas |
| 2023 |
Short-course antibiotic
regimen
compared to conventional antibiotic treatment for gram-positive cocci
infective endocarditis: randomized clinical trial (SATIE)
|
20.006 |
SATIE |
PROTOCOLO |
Enfermedades Infecciosas |
| 2023 |
Cloxacillin plus
fosfomycin versus cloxacillin alone for methicillin-susceptible
Staphylococcus aureus bacteremia: a randomized trial
|
19.016 |
SAFO |
RESULTADOS |
Enfermedades Infecciosas |
| 2022 |
Double-blind placebo-controlled randomized clinical trial
to assess the efficacy of montelukast in mild to moderate respiratory
symptoms of patients with long COVID: E-SPERANZA COVID Project study
protocol
|
21.040 |
E-SPERANZA COVID |
PROTOCOLO |
Enfermedades Infecciosas |
| 2022 |
Early Use of Sarilumab in Patients Hospitalized with
COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR
Randomized Clinical Trial
|
20.019 |
SARICOR |
RESULTADOS |
Enfermedades Infecciosas |
| 2022 |
Study protocol
for a randomized clinical trial to assess 7 versus 14-days of treatment
for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2
trial).
|
21.028 |
SHORTEN II |
PROTOCOLO |
Enfermedades Infecciosas |
| 2022 |
Seven-versus 14-day
course of antibiotics for the treatment of bloodstream infections by
Enterobacterales: a randomized, controlled trial
|
15.011 |
SHORTEN I |
RESULTADOS |
Enfermedades Infecciosas |
| 2022 |
Effectiveness of Fosfomycin for
the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary
Tract Infections A
Randomized Clinical Trial
|
14.005 |
FOREST |
RESULTADOS |
Enfermedades Infecciosas |
| 2021 |
Clinical
effectiveness and bacteriological eradication of three different
Short-COurse antibiotic regimens and single-dose fosfomycin for
uncomplicated lower Urinary Tract infections in adult women (SCOUT
study): study protocol for a randomised clinical trial
|
21.026 |
SCOUT |
PROTOCOLO |
Enfermedades Infecciosas |
| 2021 |
Vaccination adjuvated against hepatitis B in Spanish
National Healthcare System
(SNS) workers typed as non-responders to conventional vaccines
|
17.027 |
VACANTIB |
RESULTADOS |
Enfermedades Infecciosas |
| 2021 |
Temocillin
versus
meropenem for the
targeted treatment of bacteraemia due to third-generation
cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a
randomised, pragmatic
trial
|
20.004 |
ASTARTE |
PROTOCOLO |
Enfermedades Infecciosas |
| 2020 |
Efficacy and safety of early treatment with sarilumab in
hospitalised adults with COVID-19 presenting cytokine release syndrome
(SARICOR STUDY): protocol of a phase II, open-label, randomised,
multicentre, controlled clinical trial
|
20.019 |
SARICOR |
PROTOCOLO |
Enfermedades Infecciosas |
| 2020 |
Randomised
multicentre clinical trial to evaluate voriconazole pre-emptive
genotyping strategy in patients
with risk of aspergillosis: vorigenipharm study protocol
|
19.002 |
VORIGEPHARM |
PROTOCOLO |
Enfermedades Infecciosas |
| 2019 |
Effectiveness of antitussives, anticholinergics or honey
versus usual care in adults with uncomplicated acute bronchitis: a study
protocol of an open randomised clinical trial in primary care
|
17029 |
AB4T |
PROTOCOLO |
Enfermedades Infecciosas |
| 2019 |
Opportunities for antibiotic optimisation and outcome
improvement in patients with negative blood cultures: study protocol for
a cluster-randomised crossover trial, the NO-BACTstudy
|
18.010 |
NO_BACT |
PROTOCOLO |
Enfermedades Infecciosas |
| 2018 |
Population
pharmacokinetics and
pharmacodynamics of fosfomycin in non-critically ill patients with
bacteremic urinary infection
caused by multidrug-resistant Escherichia coli
|
14.005 |
FOREST |
RESULTADOS |
Enfermedades Infecciosas |
| 2018 |
Efficacy
and safety of the
combination of reduced duration prophylaxis followed by immuno-guided
prophylaxis to prevent
cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY):
an open-label,
randomised, non-inferiority clinical trial
|
18.008 |
CYTOCOR |
PROTOCOLO |
Enfermedades Infecciosas |
| 2017 |
Optimisation of empirical
antimicrobial therapy in patients with haematological malignancies and
febrile neutropenia (How
Long study): an open-label, randomised, controlled phase 4 trial
|
15.010 |
HOW LONG |
RESULTADOS |
Enfermedades Infecciosas |
| 2017 |
Targeted simplification versus antipseudomonal
broad-spectrum betalactams in patients with bloodstream infections due
to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre,
open-label, phase III randomised, controlled, non-inferiority clinical
trial
|
16.001 |
SIMPLIFY |
PROTOCOLO |
Enfermedades Infecciosas |